 | • レポートコード：D005-00127 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：機械・装置 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオシミュレーションの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオシミュレーションの種類別市場規模（分子シミュレーション、臨床試験、毒性予測ソフトウェア、その他）、用途別市場規模（病院、科学研究機関、政府部、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Accelrys、Entelos Holding Corporation、Dassault Systems SA、Certara、Chemical Computing Group、Simulation Plus、Physiomics PLC、Advanced Chemistry Development、Schrodinger、Genedata AG ・地域別グローバル市場分析 2015年-2020年 ・バイオシミュレーションの北米市場（アメリカ、カナダ、メキシコ） ・バイオシミュレーションのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオシミュレーションのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオシミュレーションの南米市場（ブラジル、アルゼンチン） ・バイオシミュレーションの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：分子シミュレーション、臨床試験、毒性予測ソフトウェア、その他 ・用途別分析：病院、科学研究機関、政府部、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Biosimulation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.2% in the forecast period of 2020 to 2025 and will expected to reach USD 2574.1 million by 2025, from USD 1626 million in 2019.
The Biosimulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biosimulation market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biosimulation market has been segmented into:
Molecular Simulation
Clinical Trials
Toxicity Prediction Software
Other
By Application, Biosimulation has been segmented into:
Hospital
Scientific Research Institutions
Government Department
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biosimulation market presented in the report. This section sheds light on the sales growth of different regional and country-level Biosimulation markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biosimulation market.
The report offers in-depth assessment of the growth and other aspects of the Biosimulation market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biosimulation Market Share Analysis
Biosimulation competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biosimulation sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biosimulation sales, revenue and market share for each player covered in this report.
The major players covered in Biosimulation are:
Accelrys
Entelos Holding Corporation
Dassault Systems SA
Certara
Chemical Computing Group
Simulation Plus
Physiomics PLC
Advanced Chemistry Development
Schrodinger
Genedata AG
Table of Contents
1 Biosimulation Market Overview
1.1 Product Overview and Scope of Biosimulation
1.2 Classification of Biosimulation by Type
1.2.1 Global Biosimulation Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biosimulation Revenue Market Share by Type in 2019
1.2.3 Molecular Simulation
1.2.4 Clinical Trials
1.2.5 Toxicity Prediction Software
1.2.6 Other
1.3 Global Biosimulation Market by Application
1.3.1 Overview: Global Biosimulation Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Scientific Research Institutions
1.3.4 Government Department
1.3.5 Other
1.4 Global Biosimulation Market by Regions
1.4.1 Global Biosimulation Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biosimulation (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biosimulation Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biosimulation Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimulation Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biosimulation Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimulation Status and Prospect (2015-2025)
2 Company Profiles
2.1 Accelrys
2.1.1 Accelrys Details
2.1.2 Accelrys Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Accelrys SWOT Analysis
2.1.4 Accelrys Product and Services
2.1.5 Accelrys Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.2 Entelos Holding Corporation
2.2.1 Entelos Holding Corporation Details
2.2.2 Entelos Holding Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Entelos Holding Corporation SWOT Analysis
2.2.4 Entelos Holding Corporation Product and Services
2.2.5 Entelos Holding Corporation Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dassault Systems SA
2.3.1 Dassault Systems SA Details
2.3.2 Dassault Systems SA Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Dassault Systems SA SWOT Analysis
2.3.4 Dassault Systems SA Product and Services
2.3.5 Dassault Systems SA Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.4 Certara
2.4.1 Certara Details
2.4.2 Certara Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Certara SWOT Analysis
2.4.4 Certara Product and Services
2.4.5 Certara Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.5 Chemical Computing Group
2.5.1 Chemical Computing Group Details
2.5.2 Chemical Computing Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Chemical Computing Group SWOT Analysis
2.5.4 Chemical Computing Group Product and Services
2.5.5 Chemical Computing Group Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.6 Simulation Plus
2.6.1 Simulation Plus Details
2.6.2 Simulation Plus Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Simulation Plus SWOT Analysis
2.6.4 Simulation Plus Product and Services
2.6.5 Simulation Plus Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.7 Physiomics PLC
2.7.1 Physiomics PLC Details
2.7.2 Physiomics PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Physiomics PLC SWOT Analysis
2.7.4 Physiomics PLC Product and Services
2.7.5 Physiomics PLC Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.8 Advanced Chemistry Development
2.8.1 Advanced Chemistry Development Details
2.8.2 Advanced Chemistry Development Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Advanced Chemistry Development SWOT Analysis
2.8.4 Advanced Chemistry Development Product and Services
2.8.5 Advanced Chemistry Development Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.9 Schrodinger
2.9.1 Schrodinger Details
2.9.2 Schrodinger Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Schrodinger SWOT Analysis
2.9.4 Schrodinger Product and Services
2.9.5 Schrodinger Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genedata AG
2.10.1 Genedata AG Details
2.10.2 Genedata AG Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genedata AG SWOT Analysis
2.10.4 Genedata AG Product and Services
2.10.5 Genedata AG Biosimulation Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biosimulation Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biosimulation Players Market Share
3.2.2 Top 10 Biosimulation Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biosimulation Revenue and Market Share by Regions
4.2 North America Biosimulation Revenue and Growth Rate (2015-2020)
4.3 Europe Biosimulation Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biosimulation Revenue and Growth Rate (2015-2020)
4.5 South America Biosimulation Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biosimulation Revenue and Growth Rate (2015-2020)
5 North America Biosimulation Revenue by Countries
5.1 North America Biosimulation Revenue by Countries (2015-2020)
5.2 USA Biosimulation Revenue and Growth Rate (2015-2020)
5.3 Canada Biosimulation Revenue and Growth Rate (2015-2020)
5.4 Mexico Biosimulation Revenue and Growth Rate (2015-2020)
6 Europe Biosimulation Revenue by Countries
6.1 Europe Biosimulation Revenue by Countries (2015-2020)
6.2 Germany Biosimulation Revenue and Growth Rate (2015-2020)
6.3 UK Biosimulation Revenue and Growth Rate (2015-2020)
6.4 France Biosimulation Revenue and Growth Rate (2015-2020)
6.5 Russia Biosimulation Revenue and Growth Rate (2015-2020)
6.6 Italy Biosimulation Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biosimulation Revenue by Countries
7.1 Asia-Pacific Biosimulation Revenue by Countries (2015-2020)
7.2 China Biosimulation Revenue and Growth Rate (2015-2020)
7.3 Japan Biosimulation Revenue and Growth Rate (2015-2020)
7.4 Korea Biosimulation Revenue and Growth Rate (2015-2020)
7.5 India Biosimulation Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biosimulation Revenue and Growth Rate (2015-2020)
8 South America Biosimulation Revenue by Countries
8.1 South America Biosimulation Revenue by Countries (2015-2020)
8.2 Brazil Biosimulation Revenue and Growth Rate (2015-2020)
8.3 Argentina Biosimulation Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biosimulation by Countries
9.1 Middle East & Africa Biosimulation Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biosimulation Revenue and Growth Rate (2015-2020)
9.3 UAE Biosimulation Revenue and Growth Rate (2015-2020)
9.4 Egypt Biosimulation Revenue and Growth Rate (2015-2020)
9.5 South Africa Biosimulation Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biosimulation Revenue and Market Share by Type (2015-2020)
10.2 Global Biosimulation Market Forecast by Type (2019-2024)
10.3 Molecular Simulation Revenue Growth Rate (2015-2025)
10.4 Clinical Trials Revenue Growth Rate (2015-2025)
10.5 Toxicity Prediction Software Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Biosimulation Market Segment by Application
11.1 Global Biosimulation Revenue Market Share by Application (2015-2020)
11.2 Biosimulation Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Scientific Research Institutions Revenue Growth (2015-2020)
11.5 Government Department Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Biosimulation Market Size Forecast (2021-2025)
12.1 Global Biosimulation Market Size Forecast (2021-2025)
12.2 Global Biosimulation Market Forecast by Regions (2021-2025)
12.3 North America Biosimulation Revenue Market Forecast (2021-2025)
12.4 Europe Biosimulation Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biosimulation Revenue Market Forecast (2021-2025)
12.6 South America Biosimulation Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biosimulation Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biosimulation Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biosimulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biosimulation Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biosimulation Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Accelrys Corporate Information, Location and Competitors
Table 6. Accelrys Biosimulation Major Business
Table 7. Accelrys Biosimulation Total Revenue (USD Million) (2017-2018)
Table 8. Accelrys SWOT Analysis
Table 9. Accelrys Biosimulation Product and Solutions
Table 10. Accelrys Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Entelos Holding Corporation Corporate Information, Location and Competitors
Table 12. Entelos Holding Corporation Biosimulation Major Business
Table 13. Entelos Holding Corporation Biosimulation Total Revenue (USD Million) (2018-2019)
Table 14. Entelos Holding Corporation SWOT Analysis
Table 15. Entelos Holding Corporation Biosimulation Product and Solutions
Table 16. Entelos Holding Corporation Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Dassault Systems SA Corporate Information, Location and Competitors
Table 18. Dassault Systems SA Biosimulation Major Business
Table 19. Dassault Systems SA Biosimulation Total Revenue (USD Million) (2017-2018)
Table 20. Dassault Systems SA SWOT Analysis
Table 21. Dassault Systems SA Biosimulation Product and Solutions
Table 22. Dassault Systems SA Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Certara Corporate Information, Location and Competitors
Table 24. Certara Biosimulation Major Business
Table 25. Certara Biosimulation Total Revenue (USD Million) (2017-2018)
Table 26. Certara SWOT Analysis
Table 27. Certara Biosimulation Product and Solutions
Table 28. Certara Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Chemical Computing Group Corporate Information, Location and Competitors
Table 30. Chemical Computing Group Biosimulation Major Business
Table 31. Chemical Computing Group Biosimulation Total Revenue (USD Million) (2017-2018)
Table 32. Chemical Computing Group SWOT Analysis
Table 33. Chemical Computing Group Biosimulation Product and Solutions
Table 34. Chemical Computing Group Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Simulation Plus Corporate Information, Location and Competitors
Table 36. Simulation Plus Biosimulation Major Business
Table 37. Simulation Plus Biosimulation Total Revenue (USD Million) (2017-2018)
Table 38. Simulation Plus SWOT Analysis
Table 39. Simulation Plus Biosimulation Product and Solutions
Table 40. Simulation Plus Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Physiomics PLC Corporate Information, Location and Competitors
Table 42. Physiomics PLC Biosimulation Major Business
Table 43. Physiomics PLC Biosimulation Total Revenue (USD Million) (2017-2018)
Table 44. Physiomics PLC SWOT Analysis
Table 45. Physiomics PLC Biosimulation Product and Solutions
Table 46. Physiomics PLC Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Advanced Chemistry Development Corporate Information, Location and Competitors
Table 48. Advanced Chemistry Development Biosimulation Major Business
Table 49. Advanced Chemistry Development Biosimulation Total Revenue (USD Million) (2017-2018)
Table 50. Advanced Chemistry Development SWOT Analysis
Table 51. Advanced Chemistry Development Biosimulation Product and Solutions
Table 52. Advanced Chemistry Development Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Schrodinger Corporate Information, Location and Competitors
Table 54. Schrodinger Biosimulation Major Business
Table 55. Schrodinger Biosimulation Total Revenue (USD Million) (2017-2018)
Table 56. Schrodinger SWOT Analysis
Table 57. Schrodinger Biosimulation Product and Solutions
Table 58. Schrodinger Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Genedata AG Corporate Information, Location and Competitors
Table 60. Genedata AG Biosimulation Major Business
Table 61. Genedata AG Biosimulation Total Revenue (USD Million) (2017-2018)
Table 62. Genedata AG SWOT Analysis
Table 63. Genedata AG Biosimulation Product and Solutions
Table 64. Genedata AG Biosimulation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Biosimulation Revenue (Million USD) by Players (2015-2020)
Table 66. Global Biosimulation Revenue Share by Players (2015-2020)
Table 67. Global Biosimulation Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Biosimulation Revenue Market Share by Regions (2015-2020)
Table 69. North America Biosimulation Revenue by Countries (2015-2020)
Table 70. North America Biosimulation Revenue Market Share by Countries (2015-2020)
Table 71. Europe Biosimulation Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Biosimulation Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Biosimulation Revenue by Countries (2015-2020)
Table 74. South America Biosimulation Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Biosimulation Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Biosimulation Revenue Market Share by Countries (2015-2020)
Table 77. Global Biosimulation Revenue (Million USD) by Type (2015-2020)
Table 78. Global Biosimulation Revenue Share by Type (2015-2020)
Table 79. Global Biosimulation Revenue Forecast by Type (2021-2025)
Table 80. Global Biosimulation Revenue by Application (2015-2020)
Table 81. Global Biosimulation Revenue Share by Application (2015-2020)
Table 82. Global Biosimulation Revenue Forecast by Application (2021-2025)
Table 83. Global Biosimulation Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biosimulation Picture
Figure 2. Global Biosimulation Revenue Market Share by Type in 2019
Figure 3. Molecular Simulation Picture
Figure 4. Clinical Trials Picture
Figure 5. Toxicity Prediction Software Picture
Figure 6. Other Picture
Figure 7. Biosimulation Revenue Market Share by Application in 2019
Figure 8. Hospital Picture
Figure 9. Scientific Research Institutions Picture
Figure 10. Government Department Picture
Figure 11. Other Picture
Figure 12. Global Biosimulation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Biosimulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Biosimulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Biosimulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Biosimulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Biosimulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Biosimulation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Biosimulation Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Biosimulation Revenue Market Share in 2019
Figure 21. Global Top 10 Players Biosimulation Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Biosimulation Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Biosimulation Revenue Market Share by Regions (2015-2020)
Figure 25. Global Biosimulation Revenue Market Share by Regions in 2018
Figure 26. North America Biosimulation Revenue and Growth Rate (2015-2020)
Figure 27. Europe Biosimulation Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Biosimulation Revenue and Growth Rate (2015-2020)
Figure 29. South America Biosimulation Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Biosimulation Revenue and Growth Rate (2015-2020)
Figure 31. North America Biosimulation Revenue Market Share by Countries (2015-2020)
Figure 32. North America Biosimulation Revenue Market Share by Countries in 2019
Figure 33. USA Biosimulation Revenue and Growth Rate (2015-2020)
Figure 34. Canada Biosimulation Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Biosimulation Revenue and Growth Rate (2015-2020)
Figure 36. Europe Biosimulation Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Biosimulation Revenue Market Share by Countries in 2019
Figure 38. Germany Biosimulation Revenue and Growth Rate (2015-2020)
Figure 39. UK Biosimulation Revenue and Growth Rate (2015-2020)
Figure 40. France Biosimulation Revenue and Growth Rate (2015-2020)
Figure 41. Russia Biosimulation Revenue and Growth Rate (2015-2020)
Figure 42. Italy Biosimulation Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Biosimulation Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Biosimulation Revenue Market Share by Countries in 2019
Figure 45. China Biosimulation Revenue and Growth Rate (2015-2020)
Figure 46. Japan Biosimulation Revenue and Growth Rate (2015-2020)
Figure 47. Korea Biosimulation Revenue and Growth Rate (2015-2020)
Figure 48. India Biosimulation Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Biosimulation Revenue and Growth Rate (2015-2020)
Figure 50. South America Biosimulation Revenue Market Share by Countries (2015-2020)
Figure 51. South America Biosimulation Revenue Market Share by Countries in 2019
Figure 52. Brazil Biosimulation Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Biosimulation Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Biosimulation Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Biosimulation Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Biosimulation Revenue and Growth Rate (2015-2020)
Figure 57. UAE Biosimulation Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Biosimulation Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Biosimulation Revenue and Growth Rate (2015-2020)
Figure 60. Global Biosimulation Revenue Share by Type (2015-2020)
Figure 61. Global Biosimulation Revenue Share by Type in 2019
Figure 62. Global Biosimulation Market Share Forecast by Type (2021-2025)
Figure 63. Global Molecular Simulation Revenue Growth Rate (2015-2020)
Figure 64. Global Clinical Trials Revenue Growth Rate (2015-2020)
Figure 65. Global Toxicity Prediction Software Revenue Growth Rate (2015-2020)
Figure 66. Global Other Revenue Growth Rate (2015-2020)
Figure 67. Global Biosimulation Revenue Share by Application (2015-2020)
Figure 68. Global Biosimulation Revenue Share by Application in 2019
Figure 69. Global Biosimulation Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Scientific Research Institutions Revenue Growth Rate (2015-2020)
Figure 72. Global Government Department Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global Biosimulation Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Biosimulation Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Biosimulation Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Biosimulation Revenue Market Forecast (2021-2025)
Figure 78. Europe Biosimulation Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Biosimulation Revenue Market Forecast (2021-2025)
Figure 80. South America Biosimulation Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Biosimulation Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
体外毒性/毒性試験の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global In-Vitro Toxicology/ Toxicity Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The In-Vitr…- 軍事シミュレーション及び訓練の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Military Simulation and Training market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14390 million by 2025, from USD 12680 million in 2019. The Milit…
- 毒性抑制複合樹脂の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Toxicity Retardant Composite Resin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Toxicity R…
- 火災・煙・毒性（FST）複合樹脂の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Fire, Smoke, and Toxicity Retardant (FST) Composite Resin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million …
- 火災・煙・毒性用複合樹脂の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Fire, Smoke, and Toxicity Retardant Composite Resin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…